{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T13:23:25Z","timestamp":1740144205854,"version":"3.37.3"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81501359"],"award-info":[{"award-number":["81501359"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81671553"],"award-info":[{"award-number":["81671553"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Wuxi Science and Technology Development Fund Project","award":["CSE31N171"],"award-info":[{"award-number":["CSE31N171"]}]},{"name":"Wuxi Health and Family Planning Committee Youth Project","award":["Q201765"],"award-info":[{"award-number":["Q201765"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>Little is known about the decay kinetics of interferon (IFN)-\u03b3 response and its influencing factors in tuberculous pleurisy. We enrolled thirty-two patients with tuberculous pleurisy prospectively and followed up at month 0, 6, and 9, at which time peripheral venous blood was drawn for interferon gamma release assay (IGRA) by means of QuantiFERON-TB Gold In-Tube (QFT-GIT). Demographic and clinical data were captured. To identify significant predictive factors influencing the IFN-\u03b3 response, multiple linear regression analyses were performed. Percentage of CD4+, CD8+, V\u03b32V\u03b42 T cells and Treg cells were measured by flow cytometry. The percentage of QFT-GIT-positive patients at baseline, month 6 and month 9 were 96.9% (30\/32), 90.6% (29\/32) and 84.4% (27\/32), respectively. Quantitative IFN-\u03b3 response at baseline were significantly correlated with symptom duration (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.003, R<jats:sup>2<\/jats:sup>\u200a=\u200a0.261) and age (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.041, R<jats:sup>2<\/jats:sup>\u200a=\u200a0.132). Besides, the decreases of the IFN-\u03b3 response at month 6 and month 9 were positively correlated with the IFN-\u03b3 level at baseline. The dynamic tendency of the percentages of Treg cells was similar to the IFN-\u03b3 responses at each time-point. Quantitative IFN-\u03b3 response could be influenced by host immune status, instead of disease burden and anti-tuberculosis treatment. IGRA is probably not a useful biomarker of treatment efficacy in tuberculous pleurisy.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000018367","type":"journal-article","created":{"date-parts":[[2020,1,8]],"date-time":"2020-01-08T17:33:41Z","timestamp":1578504821000},"page":"e18367","source":"Crossref","is-referenced-by-count":2,"title":["Serial anti-tuberculous immune responses during the follow-up of patients with tuberculous pleurisy"],"prefix":"10.1097","volume":"99","author":[{"given":"Bing-Yan","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases, Huashan Hospital, Fudan University, Shanghai"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-Min","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Diseases, Fifth People Hospital of Wuxi, Wuxi"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing-Luan","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Huashan Hospital, Fudan University, Shanghai"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian-Qian","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Huashan Hospital, Fudan University, Shanghai"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua-Xin","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Diseases, Fifth People Hospital of Wuxi, Wuxi"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Huashan Hospital, Fudan University, Shanghai"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sen","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Huashan Hospital, Fudan University, Shanghai"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling-Yun","family":"Shao","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Huashan Hospital, Fudan University, Shanghai"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin-Hua","family":"Weng","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Huashan Hospital, Fudan University, Shanghai"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qin-Fang","family":"Ou","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Diseases, Fifth People Hospital of Wuxi, Wuxi"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Huashan Hospital, Fudan University, Shanghai"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Hong","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Huashan Hospital, Fudan University, Shanghai"},{"name":"Key Laboratory of Medical Molecular Virology (MOE\/MOH) and Institutes of Biomedical Sciences, Shanghai Medical College"},{"name":"National Clinical Research Center for Aging and Medicine, Huashan Hospital"},{"name":"State Key Laboratory of Genetic Engineering, School of Life Science, Fudan University, Shanghai, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2020,1]]},"reference":[{"key":"R1-20230915","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1378\/chest.09-2350","article-title":"Evidence-based comparison of commercial interferon-gamma release assays for detecting active TB: a metaanalysis","volume":"137","author":"Diel","year":"2010","journal-title":"Chest"},{"key":"R2-20230915","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1164\/ajrccm.163.4.2009100","article-title":"Rapid detection of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells","volume":"163","author":"Lalvani","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"R3-20230915","doi-asserted-by":"crossref","first-page":"5217","DOI":"10.4049\/jimmunol.167.9.5217","article-title":"Direct ex vivo analysis of antigen-specific IFN-gamma-secreting CD4 T cells in Mycobacterium tuberculosis-infected individuals: associations with clinical disease state and effect of treatment","volume":"167","author":"Pathan","year":"2001","journal-title":"J Immunol"},{"key":"R4-20230915","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.tube.2015.07.002","article-title":"Interferon gamma release assays for monitoring the response to treatment for tuberculosis: a systematic review","volume":"95","author":"Clifford","year":"2015","journal-title":"Tuberculosis (Edinb)"},{"key":"R5-20230915","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/MCP.0b013e328339cf6e","article-title":"Pleural tuberculosis: an update","volume":"16","author":"Udwadia","year":"2010","journal-title":"Curr Opin Pulm Med"},{"key":"R6-20230915","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1159\/000323184","article-title":"Adapted T cell interferon-gamma release assay for the diagnosis of pleural tuberculosis","volume":"82","author":"Ates","year":"2011","journal-title":"Respiration"},{"key":"R7-20230915","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.humimm.2015.09.039","article-title":"Characterization of CD4\/CD8+ alphabeta and Vgamma2Vdelta2+ T cells in HIV-negative individuals with different Mycobacterium tuberculosis infection statuses","volume":"76","author":"Gao","year":"2015","journal-title":"Hum Immunol"},{"key":"R8-20230915","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.tube.2015.02.039","article-title":"The impact of anti-tuberculous antibiotics and corticosteroids on cytokine production in QuantiFERON-TB Gold In Tube assays","volume":"95","author":"Clifford","year":"2015","journal-title":"Tuberculosis (Edinb)"},{"key":"R9-20230915","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1128\/JCM.02278-12","article-title":"Gamma interferon release assay for monitoring of treatment response for active tuberculosis: an explosion in the spaghetti factory","volume":"51","author":"Denkinger","year":"2013","journal-title":"J Clin Microbiol"},{"key":"R10-20230915","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.jinf.2014.06.007","article-title":"Association between tuberculosis recurrence and interferon-gamma response during treatment","volume":"69","author":"Hang","year":"2014","journal-title":"J Infect"},{"key":"R11-20230915","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1164\/rccm.201409-1590LE","article-title":"Relation between recurrence of tuberculosis and transitional changes in IFN-gamma release assays","volume":"191","author":"Kaneko","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"R12-20230915","article-title":"Decay kinetics of an interferon gamma release assay with anti-tuberculosis therapy in newly diagnosed tuberculosis cases","volume":"9","author":"Adetifa","year":"2010","journal-title":"PLoS One"},{"key":"R13-20230915","first-page":"215","article-title":"The effect of antituberculosis treatment on interferon-gamma release assay results","volume":"75","author":"Bugiani","year":"2011","journal-title":"Monaldi Arch Chest Dis"},{"key":"R14-20230915","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/S1473-3099(14)71085-0","article-title":"Latent tuberculosis infection in rural China: baseline results of a population-based, multicentre, prospective cohort study","volume":"15","author":"Gao","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"R15-20230915","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s10238-014-0296-3","article-title":"Influencial factors of the performance of interferon-gamma release assays in the diagnosis of childhood tuberculosis","volume":"15","author":"Li","year":"2015","journal-title":"Clin Exp Med"},{"key":"R16-20230915","doi-asserted-by":"crossref","first-page":"e0103763","DOI":"10.1371\/journal.pone.0103763","article-title":"Fluctuating behavior and influential factors in the performance of the QuantiFERON-TB gold in-tube assay in the diagnosis of tuberculosis","volume":"10","author":"Bao","year":"2015","journal-title":"PLoS One"},{"key":"R17-20230915","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1164\/rccm.201208-1352OC","article-title":"Interferon-gamma ELISPOT as a biomarker of treatment efficacy in latent tuberculosis infection: a clinical trial","volume":"187","author":"Adetifa","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"R18-20230915","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1378\/chest.11-3299","article-title":"Monthly follow-ups of interferon-gamma release assays among health-care workers in contact with patients with TB","volume":"142","author":"Park","year":"2012","journal-title":"Chest"},{"key":"R19-20230915","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.tube.2007.07.004","article-title":"Increased frequency of CD4(+)CD25(high) Treg cells inhibit BCG-specific induction of IFN-gamma by CD4(+) T cells from TB patients","volume":"87","author":"Li","year":"2007","journal-title":"Tuberculosis (Edinb)"},{"key":"R20-20230915","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1086\/511277","article-title":"Immunosuppression during active tuberculosis is characterized by decreased interferon- gamma production and CD25 expression with elevated forkhead box P3, transforming growth factor- beta, and interleukin-4 mRNA levels","volume":"195","author":"Roberts","year":"2007","journal-title":"J Infect Dis"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000018367","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T23:34:32Z","timestamp":1694820872000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000018367"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":20,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000018367","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"type":"print","value":"0025-7974"},{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2020,1]]}}}